Comparing patient outcomes between multiple ipsilateral iliac artery stents and isolated iliac artery stents

被引:9
作者
Danczyk, Rachel C. [1 ]
Mitchell, Erica L. [1 ]
Burk, Chad [1 ]
Singh, Sarguni [1 ]
Liem, Timothy K. [1 ]
Landry, Gregory J. [1 ]
Petersen, Bryan D. [2 ,3 ]
Moneta, Gregory L. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Div Vasc Surg, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Dotter Inst, Portland, OR 97239 USA
[3] Oregon Hlth & Sci Univ, Portland Vet Affairs Med Ctr, Portland, OR 97239 USA
关键词
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; AORTOILIAC OCCLUSIVE DISEASE; CONSENSUS-CLASS-C; ENDOVASCULAR TREATMENT; PREDICTORS; LESIONS; MULTICENTER; EXPERIENCE; ISCHEMIA; THERAPY;
D O I
10.1016/j.jvs.2011.12.048
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Endovascular stents are accepted therapy for iliac artery stenoses and occlusions. Surgery is the recommended therapy for patients with severe iliac artery disease, including those with the combination of ipsilateral common iliac artery (CIA) and external iliac artery (EIA) stenoses/occlusions. This study compared patient outcomes, including late open conversion rates, for combined ipsilateral CIA and EIA stenting vs CIA or EIA stents alone. Methods: Between 1998 and 2010, 588 patients underwent iliac artery stenting at two institutions. Patient comorbidities and outcomes were retrospectively reviewed, and analyses were performed using multivariate regression and Kaplan-Meier methods. Results: There were 436 extremities with CIA stents, 195 with EIA stents, and 157 with CIA and EIA stents. The groups did not differ significantly in demographics, comorbidities, or treatment indications. During follow-up, 183 patients died, 95 underwent an endovascular reintervention, and 48 required late open conversion. For patients in the CIA or EIA stent group, the mean +/- standard error survival was 5.3 +/- 0.3 years, secondary endovascular intervention-free survival was 7.4 +/- 0.6 years, late open conversion-free survival was 9.8 +/- 0.4 years, and amputation-free survival was 7.6 +/- 0.4 years. In the CIA and EIA stent group, survival was 6.1 +/- 0.6 years, secondary endovascular intervention-free survival was 7.2 +/- 0.6 years, late open conversion-free survival was 9.0 +/- 1.1 years, and amputation-free survival was 8.4 +/- 0.5 years. Survival, reintervention-free survival, late open conversion-free survival, and amputation-free survival were all similar between patient groups (all P > .05). CIA and EIA stenting in combination was not a predictor of death, reintervention, late open conversion, or amputation. Conclusions: Outcomes are similar for patients with CIA or EIA stents and for those with combined ipsilateral CIA and EIA stents. Late open conversions for iliac artery stent failure are uncommon and not influenced by the location or extent of prior iliac artery stent placement. Endovascular therapy for aortoiliac disease should be extended to consider selected patients with ipsilateral CIA and EIA stenoses/occlusions. (J Vasc Surg 2012; 55: 1637-46.)
引用
收藏
页码:1637 / U411
页数:16
相关论文
共 20 条
[1]   Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial [J].
Bradbury, AW ;
Ruckley, CV ;
Fowkes, FGR ;
Forbes, JF ;
Gillespie, I ;
Adam, DJ ;
Beard, JD ;
Cleveland, T ;
Bell, J ;
Raab, G ;
Storkey, H .
LANCET, 2005, 366 (9501) :1925-1934
[2]   Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery [J].
Conte, MS ;
Bandyk, DF ;
Clowes, AW ;
Moneta, GL ;
Seely, L ;
Lorenz, TJ ;
Namini, H ;
Hamdan, AD ;
Roddy, SP ;
Belkin, M ;
Berceli, SA ;
DeMasi, RJ ;
Samson, RH ;
Berman, SS .
JOURNAL OF VASCULAR SURGERY, 2006, 43 (04) :742-750
[3]  
Damaraju S, 1997, TEX HEART I J, V24, P173
[4]   Clinical outcomes and implications of failed infrainguinal endovascular stents [J].
Gur, Ilia ;
Lee, William ;
Akopian, Gabriel ;
Rowe, Vincent L. ;
Weaver, Fred A. ;
Katz, Steven G. .
JOURNAL OF VASCULAR SURGERY, 2011, 53 (03) :658-666
[5]   Results of endovascular therapy and aortobifemoral grafting for Transatlantic Inter-Society type C and D aortoiliac occlusive disease [J].
Hans, Sachinder Singh ;
DeSantis, Debbie ;
Siddiqui, Rizwan ;
Khoury, Michael .
SURGERY, 2008, 144 (04) :583-590
[6]   A systematic review of endovascular treatment of extensive aortoiliac occlusive disease [J].
Jongkind, Vincent ;
Akkersdijk, George J. M. ;
Yeung, Kak K. ;
Wisselink, Willem .
JOURNAL OF VASCULAR SURGERY, 2010, 52 (05) :1376-1383
[7]   Long-term outcomes and predictors of iliac angioplasty with selective stenting [J].
Kudo, T ;
Chandra, FA ;
Ahn, SS .
JOURNAL OF VASCULAR SURGERY, 2005, 42 (03) :466-475
[8]   Comparing patency rates between external iliac and common iliac artery stents [J].
Lee, ES ;
Steenson, CC ;
Trimble, KE ;
Caldwell, MP ;
Kuskowski, MA ;
Santilli, SM .
JOURNAL OF VASCULAR SURGERY, 2000, 31 (05) :889-894
[9]   Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients [J].
Leville, CD ;
Kashyap, VS ;
Clair, DG ;
Bena, JF ;
Lyden, SP ;
Greenberg, RK ;
O'Hara, PJ ;
Sarac, TP ;
Ouriel, K .
JOURNAL OF VASCULAR SURGERY, 2006, 43 (01) :32-39
[10]   Aortoiliac stenting, determinants of clinical outcome [J].
Nawaz, S ;
Cleveland, T ;
Gaines, P ;
Beard, J ;
Chan, P .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1999, 17 (04) :351-359